期刊文献+

中国2009年Ⅰ型脊髓灰质炎病毒基因特征分析 被引量:10

Analysis on Genetic Characteristic of Type I Poliovirus in China in 2009
原文传递
导出
摘要 目的研究中国(未包括香港、澳门特别行政区和台湾地区,下同)2009年从急性弛缓性麻痹(Acute FlaccidParalysis,AFP)病例监测系统中,分离到的Ⅰ型脊髓灰质炎(脊灰)病毒(Poliovirus,PV)分子生物学特征,为维持无脊灰状态提供依据。方法采用逆转录-聚合酶链反应(Reverse Transcription-Polymerase Chain Reaction,RT-PCR),对I型PV的VP1编码区进行扩增,并对PCR产物进行核苷酸序列测定和分析;对VP1编码区的核苷酸突变热点和神经毒力位点进行分析,并建立亲缘关系进化树分析毒株间的进化关系。结果中国2009年从AFP病例监测系统中共分离到57株I型PV。对这57株PV进行VP1编码区核苷酸序列测定和分析,未发现PV野毒株或疫苗衍生PV。但发现5株高变异株,其中分离于两例AFP病例的两株高变异株的核苷酸序列同源性100%。同时序列比对结果表明,在VP1编码区的两个核苷酸(nt2747和nt2749)是两个突变热点。结论根据江西省和湖北省两株高变异株的流行病学及实验室检测结果,不能排除它们之间发生了短时间的循环,有待于深入研究。同时,突变热点的存在提示毒株受到选择压力的影响,容易回复突变成野生型,从而带来一系列的神经毒力等表型方面的变化。 Objective To study the molecular characteristics of type 1 poliovirus isolated from the acute flaccid paralysi(sAFP)surveillance system in China in 2009,to provide a scientific basis for maintaining polio-free status for China.Method Polymerase chain reaction(RT-PCR)method was used to amplify the VP1 code region of all the type I poliovirus,and the VP1 coding region of the isolated stains was sequenced and analyzed,the hot-spots and nuerovirulence determinant were analyzed.The phylogenetic tree was constructed based on VP1 region to analyze the evolutionary relationship between the strains.Result The results of VP1 sequencing showed that no wild strains or vaccine-derived poliovirus(VDPVs)were detected.However,five pre-VDPVs were found.And nucleotide sequences of two isolates were in high degree of similarit(y100%).Sequence alignment showed that two nucleotides in the VP1 region.nt2747 and nt2749 were two mutation hot spots.Conclusion According to the epidemiological and laboratory test results of two high variation strains,the short-term circulation may occur probably,and further research are needed.Meanwhile,the existence of mutation hot spots indicated that strains are easy to reverse into wild-type substitutions,and lead to a series changes of neurological and other virulence when the strains are under selective pressure.
出处 《中国疫苗和免疫》 CAS 2010年第2期115-121,共7页 Chinese Journal of Vaccines and Immunization
基金 科学技术部科技支撑传染病及病媒生物控制适宜技术研究--维持无脊髓灰质炎时期外环境脊髓灰质炎病毒检测技术的建立及推广应用(2008BA156B0) 科学技术部(艾滋病和病毒性肝炎等重大传染病防治科学技术重大专项)病原体网络化监测技术研究--传染病传播的相关环境因素监测和预警框架系统(2008ZX10402)
关键词 Ⅰ型脊髓灰质炎病毒 VP1编码区 基因特征 TypeⅠpoliovirus Characteristic of VP1 coding gene
  • 相关文献

参考文献14

  • 1WHO. Resurgence of Wild poliovirus types 1 and 3 in 15 African countries, January 2000-March 2009 [J ] .WER, 2009, 84 (16) : 133-140.
  • 2严冬梅,祝双利,张勇,王东艳,安洪秋,李爱英,杨建芳,温宁,李黎,唐牛良明,许文波.山西省2007年Ⅰ型疫苗衍生脊髓灰质炎病毒的鉴定和基因特性分析[J].中国疫苗和免疫,2009,15(2):131-134. 被引量:12
  • 3Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating typel vaccinederived poliovirus [J]. Science, 2002, 296(5566): 356-359.
  • 4Yang CF, Naguib T, Yang S J, et al. Circulation of endemic type 2 vaccine-derived polio virus in Egypt from 1983 to 1993[J]. J Virol, 2003.77 ( 15 ): 8366-8377.
  • 5Shimizu H, Thorley B, Paladin F J, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in2001 [J]. J Virol, 2004,78(24): 13512-13521.
  • 6Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, et al. Recombinant vaccine-derived poliovirus in Madagascar[J]. Emerg Infect Dis, 2003, 9(7 ): 885-887.
  • 7许文波,张勇,严冬梅,王东艳,赵蓉,叶绪芳,祝双利,李杰,安洪秋,张大勇,任刚,左树岩,温宁,刘铭,苏飞,刘桂艳,朱晖,唐牛良明,梁晓峰.Ⅰ型疫苗衍生脊髓灰质炎病毒循环的发现和基因特点[J].中国计划免疫,2005,11(4):252-259. 被引量:25
  • 8Kew OM, Sutter RW, de Gourville EM, et al. Vaccine derived poliovirus and the endgame strategy for global polio eradication [J]. Annu Rev Microbiol, 2005, 59: 587-635.
  • 9WHO. Polio laboratory manual [M].4th edition, Geneva, Switzerland.2004: 1-157.
  • 10Balanant J, Ouillot S, Candrea A, et al. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay [ J ] .Virology, 1991,184 ( 2 ) : 645-654.

二级参考文献49

  • 1张勇,严冬梅,王东艳,朱贞,刘中华,赵月萍,陈晓琴,祝双利,李崇山,安洪秋,许文波.我国首例iVDPV病例Ⅱ型脊髓灰质炎病毒分离株的基因特征[J].病毒学报,2007,23(3):188-194. 被引量:6
  • 2CDC.Progress toward interruption of wild poliovirus transmissionworldwide,January2005-March 2006[J].MMWR,2006,55(16):458-462.
  • 3Kew OM,Suttcr RW,de Gourville EM,et al.Vaccine-derived poliovirus and the endgame strategy for global polio eradication[J].Annu Rev Microbio,2005,59:587-635.
  • 4Kew O,Morris-Glasgow V,Landaverde M,et al.Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccinederived poliovirus[J].Science,2002,296(5566):356-359.
  • 5Martin J,Odoom K,Tuite G,et al.Long-term excretion of vaccine-derived poliovirus by a healthy child[J].J Virol,2004,78(24):13839-13847,.
  • 6WHO.Laboratory surveillance for wild and vaccine-derived polioviruses,January 2002-June2003[J].WER,2003,78(39):341-346.
  • 7Biomqvist S,Savolainen C,Laine P,et al.Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia[J].J Virol,2004,78(9):4876-4883.
  • 8WHO.Polio laboratory manual[M].4^th edition,WHO,Geneva,Switzerland,2004:83-96.
  • 9Shimizu H,Thorley B,Paladin F J,et al.Circulation of type 1 vaccinederived poliovirus in the Philippines in 2001[J],J Virok,2004,78(24):13512-13521.
  • 10Yang CF,Naguib T,Yang SJ,et al.Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993[J].J Virol,2003,77(15):8366-8377.

共引文献50

同被引文献80

引证文献10

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部